biochemical relapse, a rise in the level of prostate-specific antigen (PSA) following treatment that may provide evidence of an early recurrence but does not equal a clinical relapse.
biochemical relapse, a rise in the level of prostate-specific antigen (PSA) following treatment that may provide evidence of an early recurrence but does not equal a clinical relapse.